Introduction
============

A large number of drugs and biologically relevant molecules contain heterocyclic systems. Often the presence of hetero atoms or groupings imparts preferential specificities in their biological responses. The chemistry and biological study of heterocyclic compounds has been interesting field for a long time due to medicinal and agricultural reasons. The number of heterocyclic derivatives containing nitrogen and sulfur atom possess broad spectrum of biological activities. One of the most important heterocycle in medicinal chemistry is pyridine with wide application including antimicrobial, anti-inflammatory, anti-HIV, antiplasmodial, anti-tubercular, antibacterial and anticonvulsant \[[@b1-scipharm-2010-78-753]--[@b7-scipharm-2010-78-753]\] activities, and has much other important biological significance.

The 4-thiazolidinone ring system comprises the broad spectrum for a number of biologically active compounds. In recent years, 4-thiazolidinones are the most extensively investigated class of compounds, which exhibit various biological activities, such as antimicrobial, anti-inflammatory, anti-HIV, anti-toxoplasma gondii and analgesic \[[@b8-scipharm-2010-78-753]--[@b12-scipharm-2010-78-753]\].

Looking towards literature, it was thought that incorporation of all these biologically active moieties might be result in better antimicrobial activity and therefore as the part of our continuous research in developing the new heterocycles containing nitrogen and sulfur atom and screening their microbial studies \[[@b13-scipharm-2010-78-753]--[@b15-scipharm-2010-78-753]\], herewith we have designed 4-thiazolidinones incorporated nicotinic acid with 2-amino-6-methylbenzothiazole and examined their antimicrobial activities.

Results and Discussion
======================

Synthesis of compounds
----------------------

2-Chloro pyridine-3-carboxylic acid **1** and 2-amino-6-methyl benzothiazole **2** in presence of anhydrous K~2~CO~3~ and Cu-bronze in DMF solvent on Ullmann condensation yielded 2-\[(6-methyl-2-benzothiazolyl)amino\]nicotinic acid (**3**). Further heating **3** with SOCl~2~ and subsequent reaction with hydrazine hydrate in chloroform formed **4** which on condensation with substituted aromatic aldehydes in DMF gave **5a--j**. Thaizolidinones **6a--j** were synthesized by refluxing **5a--j** and thioglycolic acid in dry 1,4-dioxane for 12--14 h using a Dean-Stark apparatus ([Scheme 1](#f3-scipharm-2010-78-753){ref-type="fig"}). Purity of the compounds was checked by TLC using ethyl acetate: toluene (1:3) as a solvent system. Structures were characterized by spectral data (FT-IR, ^1^H-NMR and ^13^C-NMR).

Investigations, Results and Discussion
--------------------------------------

The *in vitro* antibacterial and antifungal activities of the compounds are shown in [Table 1](#t1-scipharm-2010-78-753){ref-type="table"}. The MICs (μg/ml) were carried out by broth microdilution method as described by Rattan \[[@b17-scipharm-2010-78-753]\].

### Antibacterial Activity

From the screening results ([Table 1](#t1-scipharm-2010-78-753){ref-type="table"}), it is evident that compound **1** displayed good to moderate activity against all bacteria (150--250 μg/ml). 2-Amino-6-methylbenzothiazole (**2**), compound **3** and hydrazide **4** exhibited moderate to poor activity against all bacteria.

The result shows that compounds **5a**, **5e**, **5j**, **6d**, **6g** and **6j** exhibited good activity (25--100 μg/ml) against *E. coli*; **5d**, **5j**, **6d**, **6i** and **6j** exhibited good activity (50--100 μg/ml) against *P. aeruginosa*; **5a**, **5e**, **5f**, **5h**, **5j**, **6d**, **6b** and **6j** showed good to very good activity (25--150 μg/ml) against *S. aureus*; whereas **5b**, **5h**, **5j**, **6c**, **6i** and **6j** showed good activity (62.5--100 μg/ml) against *S. pyogenes* compared with ampicillin. All other compounds showed moderate activity.

### Antifungal Activity

From the results of the antifungal activity ([Table 1](#t1-scipharm-2010-78-753){ref-type="table"}), it is evident that compounds **1, 2, 3** and **4** showed good to moderate activity against *C. albicans*.

Results also show that Schiff bases and 4-thiazolidinones possessed good activity against *C. albicans* while moderate activity against *A. niger* and *A. clavatus.* Compounds **5a**, **5d**, **5g**, **5j**, **6b**, **6e**, **6f** and **6j** showed better activity (100--500 μg/ml) against *C. albicans* when compared with griseofulvin, while all compounds showed poor to moderate activity against *A. niger* and *A. clavatus.*

Conclusion
==========

Most of the compounds are comparable with ampicillin. Compounds bearing --Cl, --NO~2~ groups and furan nucleus are more active than the remaining compounds. Compounds **5a**, **5d**, **5g**, **5j**, **6b**, **6e**, **6f** and **6j** were found to be active against *C. albicans* but they found poor with other fungal species.

Experimental
============

All chemicals were of analytical grade and used directly. Melting points of the synthesized compounds were determined by open tube capillary method and were uncorrected. The purity of the compounds was checked by TLC using Merck silica gel 60 F~254~. IR spectra were recorded on a Perkin-Elmer RX 1 FTIR spectrophotometer, using potassium bromide pellets; the frequencies are expressed in cm^−1^. The ^1^H NMR and ^13^C NMR spectra were recorded with a Bruker Avance II 400 NMR spectrometer, using TMS as an internal reference, with DMSO-d*~6~* as solvent. The chemical shifts are reported in parts per million (δ ppm). Elemental analyses were performed on Carlo Erba 1180 CHN analyzer. All the results of elemental analyses were in an acceptable error range.

2-Amino-6-methylbenzothiazole (**2**), 2-\[(6-methyl-1,3-benzothiazol-2-yl)amino\]nicotinic acid (**3**) and 2-\[(6-methyl-1,3-benzothiazol-2-yl)amino\]nicotinohydrazide (**4**) were prepared by reported procedures \[[@b15-scipharm-2010-78-753], [@b16-scipharm-2010-78-753]\].

General procedure for syntheses of substituted *N'*-benzylidene/(2-furylmethylene)-2-\[(6-methyl-1,3-benzothiazol-2-yl)amino\]nicotinohydrazides (5a--j)
--------------------------------------------------------------------------------------------------------------------------------------------------------

Benzaldehyde (0.012 mole, 1.272 g) and 3--4 drops of glacial acetic acid were added to a solution of **4** (0.01 mole, 3.0 g) in DMF (30 mL). The reaction mixture was refluxed for 5--6 h and monitored by TLC on silica gel using ethyl acetate:toluene (1:3). The reaction mass was cooled and poured onto crushed ice and thus the separated solid was isolated, washed with water and recrystallized from ethanol to give **5a**. Other derivatives **5b--j** were prepared by the same method.

### *N*'-Benzylidene-2-\[(6-methyl-1,3-benzothiazol-2-yl)amino\]pyridine-3-carbohydrazide (**5a**)

White solid, yield: 52 %, mp: 180--182 °C. IR (KBr) ν cm^−1^: 3328 (NH), 1645 (amide-I), 1554 (amide-II), 1224 (Amide-III), 1616 (C=N of Schiff base), 2872, 2945 (CH~3~). ^1^H NMR (400 MHz, DMSO-d*~6~*, TMS): δ 1.25 (s, 3H, H-16), 5.84 (s, 1H, H-8), 6.81--8.58 (m, 11H, H-4,5,6,11,13,14,19,20,21,22,23), 8.84 (s, 1H, H-7), 9.34 (s, 1H, H-17); ^13^C NMR (100MHz, DMSO-d*~6~*, TMS): δ 22.1 (C-16), 112.6 (C-3), 118.3 (C-14), 119.8 (C-5), 122.4 (C-11), 127.0 (C-13), 127.9 (C-20,22), 129.9 (C-19,23), 130.9 (C-10), 132.1 (C-21), 134.6 (C-18), 136.9 (C-4), 138.4 (C-12), 143.3 (C-8), 148.2 (C-6), 151.3 (C-15), 161.5 (C-2), 162.1 (C-7), 170.5 (C-9). Anal. Calcd. for C~21~H~17~N~5~OS: C, 65.10; H, 4.43; N, 18.09. Found: C, 65.05; H, 4.38; N, 18.01.

### *N*'-(2-Chlorobenzylidene)-2-\[(6-methyl-1,3-benzothiazol-2-yl)amino\]pyridine-3-carbohydrazide (**5b**)

White solid, yield: 49 %, mp: 168--169 °C. IR (KBr) *ν* cm^−1^: 3321 (NH), 1648 (amide-I), 1552 (amide-II), 1223 (amide-III), 1614 (C=N of Schiff base), 2869, 2942 (CH~3~). ^1^H NMR (400 MHz, DMSO-d*~6~*, TMS): 1.26 (s, 3H, H-16), 5.81 (s, 1H, H-8), 6.81--8.56 (m, 10H, H-4,5,6,11,13,14,19,20,21,22), 8.87 (s, 1H, H-7), 9.36 (s, 1H, H-17). ^13^C NMR (100MHz, DMSO-d*~6~*, TMS): δ 22.3 (C-16), 112.1 (C-3), 118.3 (C-14), 119.6 (C-5), 121.9 (C-11), 126.9 (C-13), 127.1 (C-20), 127.9 (C-19), 130.4 (C-22), 130.8 (C-10), 132.3 (C-21), 133.5 (C-23), 134.9 (C-18), 136.7 (C-4), 137.9 (C-12), 143.5 (C-8), 148.1 (C-6), 150.9 (C-15), 161.7 (C-2), 162.3 (C-7), 170.1 (C-9). Anal. Calcd. for C~21~H~16~ClN~5~OS: C, 59.85; H, 3.83; N, 16.63. Found: C, 59.78; H, 3.75; N, 16.56.

### *N*'-(4-Chlorobenzylidene)-2-\[(6-methyl-1,3-benzothiazol-2-yl)amino\]pyridine-3-carbohydrazide (**5c**)

White solid, yield: 56 %, mp: 156--158 °C. IR (KBr) *ν* cm^−1^: 3319 (NH), 1642 (amide-I), 1552 (amide-II), 1223 (amide-III), 1619 (C=N of Schiff base), 2867, 2941 (CH~3~). ^1^H NMR (400 MHz, DMSO-d*~6~*, TMS): δ 1.24 (s, 3H, H-16), 5.82 (s, 1H, H-8), 6.79--8.53 (m, 10H, H-4,5,6,11,13,14,19,20,22,23), 8.86 (s, 1H, H-7), 9.38 (s, 1H, H-17). ^13^C NMR (100MHz, DMSO-d*~6~*, TMS): δ 1.25 (s, 3H, H-16), 5.84 (s, 1H, H-8), 6.81--8.58 (m, 11H, H-4,5,6,11,13,14,19,20,21,22,23), 8.84 (s, 1H, H-7), 9.34 (s, 1H, H-17); ^13^C NMR (100MHz, DMSO-d*~6~*, TMS): δ 22.5 (C-16), 112.8 (C-3), 118.1 (C-14), 119.9 (C-5), 122.1 (C-11), 126.4 (C-13), 128.4 (C-20,22), 130.3 (C-19,23), 131.0 (C-10), 133.9 (C-18), 135.7 (C-21), 137.1 (C-4), 138.3 (C-12), 144.1 (C-8), 147.9 (C-6), 151.1 (C-15), 161.9 (C-2), 163.5 (C-7), 170.4 (C-9). Anal. Calcd. for C~21~H~16~ClN~5~OS: C, 59.85; H, 3.83; N, 16.63. Found: C, 59.79; H, 3.77; N, 16.58.

### 2-\[(6-Methyl-1,3-benzothiazol-2-yl)amino\]-*N*'-(2-nitrobenzylidene)pyridine-3-carbohydrazide (**5d**)

Yellow solid, yield: 58 %, mp: 188--190 °C. IR (KBr) *ν* cm^−1^: 3322 (NH), 1640 (amide-I), 1551 (amide-II), 1221 (amide-III), 1615 (C=N of Schiff base), 2872, 2940 (CH~3~), 1370, 1512 (NO~2~). ^1^H NMR (400 MHz, DMSO-d*~6~*, TMS): δ 1.23 (s, 3H, H-16), 5.81 (s, 1H, H-8), 6.82--8.56 (m, 10H, H-4,5,6,11,13,14,19,20,21,22), 8.82 (s, 1H, H-7), 9.37 (s, 1H, H-17). ^13^C NMR (100MHz, DMSO-d*~6~*, TMS): δ 22.7 (C-16), 112.7 (C-3), 118.3 (C-14), 119.6 (C-5), 121.9 (C-11), 123.8 (C-22), 126.9 (C-13), 129.8 (C-19), 130.5 (C-10), 132.4 (C-21), 133.9 (C-20), 133.1 (C-18), 137.1 (C-4), 137.9 (C-12), 143.4 (C-8), 147.2 (C-23), 147.4 (C-6), 150.9 (C-15), 161.8 (C-2), 162.0 (C-7), 170.1 (C-9). Anal. Calcd. for C~21~H~16~N~6~O~3~S: C, 58.32; H, 3.73; N, 19.44. Found: C, 58.26; H, 3.67; N, 19.38.

### 2-\[(6-Methyl-1,3-benzothiazol-2-yl)amino\]-*N*'-(3-nitrobenzylidene)pyridine-3-carbohydrazide (**5e**)

Yellow solid, yield: 54 %, mp: 176--178 °C. IR (KBr) *ν* cm^−1^: 3321 (NH), 1641 (amide-I), 1552 (amide-II), 1226 (amide-III), 1617 (C=N of Schiff base), 2870, 2941 (CH~3~), 1369, 1511 (NO~2~). ^1^H NMR (400 MHz, DMSO-d*~6~*, TMS): δ 1.27 (s, 3H, H-16), 5.87 (s, 1H, H-8), 6.83--8.56 (m, 10H, H-4,5,6,11,13,14,19,20,21,23), 8.89 (s, 1H, H-7), 9.37 (s, 1H, H-17). ^13^C NMR (100MHz, DMSO-d*~6~*, TMS): δ 22.5 (C-16), 112.6 (C-3), 118.3 (C-14), 119.7 (C-5), 121.1 (C-11), 121.7 (C-23), 126.8 (C-13), 128.9 (C-20), 130.6 (C-10), 131.8 (C-21), 132.9 (C-19), 134.1 (C-18), 137.2 (C-4), 137.8 (C-12), 143.1 (C-8), 147.1 (C-22), 147.1 (C-6), 151.1 (C-15), 161.7 (C-2), 162.8 (C-7), 170.2 (C-9). Anal. Calcd. for C~21~H~16~N~6~O~3~S: C, 58.32; H, 3.73; N, 19.44. Found: C, 58.26; H, 3.67; N, 19.38.

### *N*'-(4-Hydroxybenzylidene)-2-\[(6-methyl-1,3-benzothiazol-2-yl)amino\]pyridine-3-carbohydrazide (**5f**)

White solid, yield: 61 %, mp: 191--192 °C. IR (KBr) *ν* cm^−1^: 3322 (NH), 1644 (amide-I), 1548 (amide-II), 1223 (amide-III), 1618 (C=N of Schiff base), 2868, 2941 (CH~3~), 3502 (OH). ^1^H NMR (400 MHz, DMSO-d*~6~*, TMS): δ 1.26 (s, 3H, H-16), 5.31 (s, 1H, H-24), 5.85 (s, 1H, H-8), 6.82--8.54 (m, 10H, H-4,5,6,11,13,14,19,20,22,23), 8.79 (s, 1H, H-7), 9.31 (s, 1H, H-17). ^13^C NMR (100MHz, DMSO-d*~6~*, TMS): δ 1.25 (s, 3H, H-16), 5.84 (s, 1H, H-8), 6.81--8.58 (m, 11H, H-4,5,6,11,13,14,19,20,21,22,23), 8.84 (s, 1H, H-7), 9.34 (s, 1H, H-17); ^13^C NMR (100MHz, DMSO-d*~6~*, TMS): δ 22.6 (C-16), 112.4 (C-3), 117.9 (C-20,22), 118.3 (C-14), 119.8 (C-5), 122.3 (C-11), 126.9 (C-13), 130.1 (C-19,23), 130.9 (C-10), 132.9 (C-18), 136.9 (C-4), 138.1 (C-12), 143.2 (C-8), 147.9 (C-6), 151.3 (C-15), 161.6 (C-2), 158.1 (C-21), 163.3 (C-7), 170.2 (C-9). Anal. Calcd. for C~21~H~17~N~5~O~2~S: C, 62.51; H, 4.25; N, 17.37. Found: C, 62.45; H, 4.18; N, 17.30.

### *N*'-(4-Methoxybenzylidene)-2-\[(6-methyl-1,3-benzothiazol-2-yl)amino\]pyridine-3-carbohydrazide (**5g**)

Brown solid, yield: 59 %, mp: 170--171 °C. IR (KBr) *ν* cm^−1^: 3321 (NH), 1643 (amide-I), 1555 (amide-II), 1228 (amide-III), 1615 (C=N of Schiff base), 2873, 2939 (CH~3~), 1039, 1179 (OCH~3~). ^1^H NMR (400 MHz, DMSO-d*~6~*, TMS): δ 1.28 (s, 3H, H-16), 3.88 (s, 1H, H-24), 5.81 (s, 1H, H-8), 6.86--8.58 (m, 10H, H-4,5,6,11,13,14,19,20,22,23), 8.86 (s, 1H, H-7), 9.34 (s, 1H, H-17). ^13^C NMR (100MHz, DMSO-d*~6~*, TMS): δ 21.9 (C-16), 55.1 (C-24), 113.1 (C-3), 115.9 (C-20,22), 118.3 (C-14), 119.7 (C-5), 121.9 (C-11), 127.1 (C-13), 129.8 (C-19,23), 131.0 (C-10), 131.9 (C-18), 136.9 (C-4), 137.1 (C-12), 142.9 (C-8), 148.0 (C-6), 151.1 (C-15), 160.8 (C-2), 162.0 (C-21), 163.1 (C-7), 170.0 (C-9). Anal. Calcd. for C~22~H~19~N~5~O~2~S: C, 63.29; H, 4.59; N, 16.79. Found: C, 63.23; H, 4.50; N, 16.70.

### *N*'-(4-Hydroxy-3-methoxybenzylidene)-2-\[(6-methyl-1,3-benzothiazol-2-yl)amino\]pyridine-3-carbohydrazide (**5h**)

White solid, yield: 64 %, mp: 145--146 °C. IR (KBr) *ν* cm^−1^: 3323 (NH), 1645 (amide-I), 1554 (amide-II), 1221 (amide-III), 1616 (C=N of Schiff base), 2874, 2942 (CH~3~), 3507 (OH). ^1^H NMR (400 MHz, DMSO-d*~6~*, TMS): δ 1.26 (s, 3H, H-16), 3.86 (s, 3H, H-24), 5.38 (s, 1H, H-25), 5.80 (s, 1H, H-8), 6.83--8.58 (m, 9H, H-4,5,6,11,13,14,19,20,23), 8.87 (s, 1H, H-7), 9.36 (s, 1H, H-17). ^13^C NMR (100MHz, DMSO-d*~6~*, TMS): δ 22.2 (C-16), 55.9 (C-24), 110.9 (C-23), 112.7 (C-3), 116.7 (C-20), 118.3 (C-14), 119.2 (C-5), 121.9 (C-11), 122.4 (C-19), 127.0 (C-13), 130.9 (C-10), 132.1 (C-18), 137.4 (C-4), 138.1 (C-12), 143.1 (C-8), 147.8 (C-6), 149.1 (C-22), 150.9 (C-15), 152.8 (C-21), 161.2 (C-2), 163.5 (C-7), 170.2 (C-9). Anal. Calcd. for C~22~H~19~N~5~O~3~S: C, 60.95; H, 4.42; N, 16.17. Found: C, 60.88; H, 4.36; N, 16.10.

### N'-(4-Hydroxy-3-methoxy-5-nitrobenzylidene)-2-\[(6-methyl-1,3-benzothiazol-2-yl)amino\]pyridine-3-carbohydrazide (**5i**)

Yellow solid, yield: 48 %, mp: 198--199 °C. IR (KBr) *ν* cm^−1^: 3324 (NH), 1647 (amide-I), 1552 (amide-II), 1225 (amide-III), 1618 (C=N of Schiff base), 2871, 2939 (CH~3~), 1037, 1181 (OCH~3~), 3503 (OH). ^1^H NMR (400 MHz, DMSO-d*~6~*, TMS): δ 1.26 (s, 3H, H-16), 3.87 (s, 3H, H-24), 5.32 (s, 1H, H-25), 5.84 (s, 1H, H-8), 6.82--8.56 (m, 8H, H-4,5,6,11,13,14,19,23), 8.87 (s, 1H, H-7), 9.37 (s, 1H, H-17). ^13^C NMR (100MHz, DMSO-d*~6~*, TMS): δ 22.5 (C-16), 55.7 (C-24), 112.6 (C-3), 117.4 (C-19), 118.0 (C-23), 118.3 (C-14), 119.7 (C-5), 121.9 (C-11), 127.0 (C-13), 129.1 (C-18), 130.6 (C-10), 136.7 (C-20), 137.4 (C-4), 138.2 (C-12), 140.8 (C-21), 143.3 (C-8), 147.7 (C-6), 150.5 (C-15), 151.7 (C-22), 161.5 (C-2), 163.1 (C-7), 170.5 (C-9). Anal. Calcd. for C~22~H~18~N~6~O~5~S: C, 55.22; H, 3.79; N, 17.57. Found: C, 55.16; H, 3.70; N, 17.50.

### *N*'-(Furan-2-ylmethylidene)-2-\[(6-methyl-1,3-benzothiazol-2-yl)amino\]pyridine-3-carbohydrazide (**5j**)

Black solid, yield: 54 %, mp: 181--184 °C, IR (KBr) *ν* cm^−1^: 3320 (NH), 1646 (amide-I), 1553 (amide-II), 1223 (amide-III), 1617 (C=N of Schiff base), 2869, 2941 (CH~3~). ^1^H NMR (400 MHz, DMSO-d*~6~*, TMS): δ 1.27 (s, 3H, H-16), 5.81 (s, 1H, H-8), 6.86--8.52 (m, 9H, H-4,5,6,11,13,14,19,20,21), 8.86 (s, 1H, H-7), 9.38 (s, 1H, H-17). ^13^C NMR (100MHz, DMSO-d*~6~*, TMS): δ 22.7 (C-16), 112.6 (C-3), 113.3 (C-20), 116.9 (C-14), 118.1(C-19), 119.8 (C-5), 121.1 (C-11), 126.3 (C-13), 130.6 (C-10), 133.3 (C-8), 136.7 (C-4), 137.4 (C-12), 143.7 (C-21), 147.2 (C-6), 148.4 (C-18), 150.3 (C-15), 161.5 (C-2), 162.7 (C-7), 170.2 (C-9). Anal. Calcd. for C~19~H~15~N~5~O~2~S: C, 60.46; H, 4.01; N, 18.57. Found: C, 60.39; H, 3.94; N, 18.50.

General procedure for syntheses of 2-\[(6-methyl-1,3-benzothiazol-2-yl)amino\]-*N*-\[2-(substituted phenyl/furan-2-yl)-4-oxo-1,3-thiazolidin-3-yl\]pyridine-3-carboxamides (6a--j)
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

A mixture of **5a** (0.01 mole, 3.87 g), thioglycolic acid (0.015 mole, 1.38 g) and a pinch of anhydrous ZnCl~2~ in dry 1,4-dioxane (30 mL) was refluxed for 12--14 h. The reaction was monitored by TLC on silica gel using ethyl acetate: toluene (1:3); was cooled and neutralized with 10% sodium bicarbonate solution. The solid product separated was filtered, washed with water and recrystallized from ethanol to give **6a**. Similarly, other 2-\[(6-methyl-1,3-benzothiazol-2-yl)amino\]-*N*-\[2-(substituted phenyl/furan-2-yl)-4-oxo-1,3-thiazolidin-3-yl\]pyridine-3-carboxamides **6b--j** have been prepared by the same method.

### 2-\[(6-Methyl-1,3-benzothiazol-2-yl)amino\]-*N*-(4-oxo-2-phenyl-1,3-thiazolidin-3-yl)pyridine-3-carboxamide (**6a**)

White solid, yield: 57 %, mp: 184--186 °C. IR (KBr) *ν* cm^−1^: 3321 (NH), 1715 (C=O of 4-thiazolidinone), 1646 (amide-I), 1556 (amide-II), 1224 (amide-III), 2878, 2950 (CH~3~). ^1^H NMR (400 MHz, DMSO-d*~6~*, TMS): δ 1.24 (s, 3H, H-18), 3.63 (s, 2H, H-9), 6.21 (s, 1H, H-10), 6.91--8.57 (m, 11H, H-4,5,6,13,15,16,21,22,23,24,25), 8.91 (s, 1H, H-7), 9.36 (s, 1H, H-19). ^13^C NMR (100MHz, DMSO-d*~6~*, TMS): δ 21.1 (C-18), 35.9 (C-9), 57.7 (C-10), 111.6 (C-3), 114.1 (C-16), 118.5 (C-5), 121.1 (C-13), 125.9 (C-15), 127.1 (C-22,24), 128.1 (C-21,25), 129.9 (C-12), 134.4 (C-14), 137.0 (C-4), 138.1 (C-20), 147.4 (C-6), 149.1 (C-17), 127.9 (C-23), 163.5 (C-2), 163.1 (C-7), 169.3 (C-8), 171.2 (C-11). Anal. Calcd. for C~23~H~19~N~5~O~2~S~2~: C, 59.86; H, 4.15; N, 15.18. Found: C, 59.80; H, 4.08; N, 15.12.

### *N*-\[2-(2-Chlorophenyl)-4-oxo-1,3-thiazolidin-3-yl\]-2-\[(6-methyl-1,3-benzothiazol-2-yl)amino\]pyridine-3-carboxamide (**6b**)

White solid, yield: 63 %, mp: 196--197 °C. IR (KBr) *ν* cm^−1^: 3322 (NH), 1718 (C=O of 4-thiazolidinone), 1644 (amide-I), 1555 (amide-II), 1225 (amide-III), 2875, 2948 (CH~3~), 755 (C-Cl). ^1^H NMR (400 MHz, DMSO-d*~6~*, TMS): δ 1.25 (s, 3H, H-18), 3.63 (s, 2H, H-9), 6.20 (s, 1H, H-10), 6.89--8.58 (m, 10H, H-4,5,6,13,15,16,21,22,23,24), 8.93 (s, 1H, H-7), 9.33 (s, 1H, H-19). ^13^C NMR (100MHz, DMSO-d*~6~*, TMS): δ 23.7 (C-18), 35.7 (C-9), 57.8 (C-10), 102.9 (C-20), 111.2 (C-3), 116.9 (C-16), 119.1 (C-5), 120.9 (C-13), 126.1 (C-15), 126.4 (C-22), 127.9 (C-24), 128.4 (C-23), 129.9 (C-12), 130.1 (C-21), 133.8 (C-25), 134.4 (C-14), 137.1 (C-4), 147.2 (C-6), 149.7 (C-17), 163.4 (C-7), 163.7 (C-2), 169.2 (C-8), 171.3 (C-11). Anal. Calcd. for C~23~H~18~ClN~5~O~2~S~2~: C, 55.75; H, 3.66; N, 14.14. Found: C, 55.70; H, 3.59; N, 14.06.

### *N*-\[2-(4-Chlorophenyl)-4-oxo-1,3-thiazolidin-3-yl\]-2-\[(6-methyl-1,3-benzothiazol-2-yl)amino\]pyridine-3-carboxamide (**6c**)

White solid, yield: 60 %, mp: 209--210 °C. IR (KBr) *ν* cm^−1^: 3323 (NH), 1716 (C=O of 4-thiazolidinone), 1646 (amide-I), 1560 (amide-II), 1226 (amide-III), 2872, 2946 (CH~3~), 756 (C-Cl). ^1^H NMR (400 MHz, DMSO-d*~6~*, TMS): δ 1.23 (s, 3H, H-18), 3.65 (s, 2H, H-9), 6.26 (s, 1H, H-10), 6.92--8.56 (m, 10H, H-4,5,6,13,15,16,21,22,24,25), 8.91 (s, 1H, H-7), 9.34 (s, 1H, H-19). ^13^C NMR (100MHz, DMSO-d*~6~*, TMS): δ 23.4 (C-18), 35.4 (C-9), 57.6 (C-10), 111.4 (C-3), 116.9 (C-16), 118.4 (C-5), 121.1 (C-13), 125.9 (C-15), 127.6 (C-22,24), 129.2 (C-21,25), 129.9 (C-12), 132.1 (C-23), 134.0 (C-14), 135.1 (C-20), 137.0 (C-4), 147.3 (C-6), 150.1 (C-17), 163.2 (C-7), 163.8 (C-2), 169.7 (C-8), 171.0 (C-11). Anal. Calcd. for C~23~H~18~ClN~5~O~2~S~2~: C, 55.75; H, 3.66; N, 14.14. Found: C, 55.69; H, 3.61; N, 14.07.

### 2-\[(6-Methyl-1,3-benzothiazol-2-yl)amino\]-*N*-\[2-(2-nitrophenyl)-4-oxo-1,3-thiazolidin-3-yl\]pyridine-3-carboxamide (**6d**)

Yellow solid, yield: 56 %, mp: 219--221 °C. IR (KBr) *ν* cm^−1^: 3319 (NH), 1718 (C=O of 4-thiazolidinone), 1644 (amide-I), 1554 (amide-II), 1224 (amide-III), 2871, 2945 (CH~3~), 1371, 1514 (NO~2~). ^1^H NMR (400 MHz, DMSO-d*~6~*, TMS): δ 1.25 (s, 3H, H-18), 3.62 (s, 2H, H-9), 6.21 (s, 1H, H-10), 6.87--8.57 (m, 10H, H-4,5,6,13,15,16,21,22,23,24), 8.92 (s, 1H, H-7), 9.35 (s, 1H, H-19). ^13^C NMR (100MHz, DMSO-d*~6~*, TMS): δ 23.6 (C-18), 35.6 (C-9), 57.1 (C-10), 111.3 (C-3), 116.5 (C-16), 118.7 (C-5), 120.9 (C-13), 124.1 (C-24), 125.9 (C-15), 127.3 (C-23), 128.9 (C-21), 129.9 (C-12), 132.6 (C-22), 133.5 (C-20), 134.4 (C-14), 137.1 (C-4), 147.3 (C-6), 148.6 (C-25), 149.8 (C-17), 163.1 (C-7), 163.6 (C-2), 169.4 (C-8), 171.1 (C-11). Anal. Calcd. for C~23~H~18~N~6~O~4~S~2~: C, 54.54; H, 3.58; N, 16.60. Found: C, 54.48; H, 3.50; N, 16.56.

### 2-\[(6-Methyl-1,3-benzothiazol-2-yl)amino\]-*N*-\[2-(3-nitrophenyl)-4-oxo-1,3-thiazolidin-3-yl\]pyridine-3-carboxamide (**6e**)

Yellow solid, yield: 52 %, mp: 213--214 °C. IR (KBr) *ν* cm^−1^: 3318 (NH), 1714 (C=O of 4-thiazolidinone), 1648 (amide-I), 1560 (amide-II), 1227 (amide-III), 2869, 2946 (CH~3~), 1365, 1510 (NO~2~). ^1^H NMR (400 MHz, DMSO-d*~6~*, TMS): δ 1.21 (s, 3H, H-18), 3.60 (s, 2H, H-9), 6.24 (s, 1H, H-10), 6.96--8.59 (m, 10H, H-4,5,6,13,15,16,21,22,23,25), 8.90 (s, 1H, H-7), 9.34 (s, 1H, H-19). ^13^C NMR (100MHz, DMSO-d*~6~*, TMS): δ 23.4 (C-18), 35.7 (C-9), 57.1 (C-10), 111.3 (C-3), 116.5 (C-16), 119.1 (C-5), 121.2 (C-13), 122.1 (C-23), 123.6 (C-22), 125.2 (C-25), 126.1 (C-15), 129.7 (C-12), 133.1 (C-21), 134.0 (C-14), 137.1 (C-4), 140.0 (C-20), 146.4 (C-24), 147.9 (C-6), 149.7 (C-17), 163.1 (C-7), 163.4 (C-2), 169.2 (C-8), 171.3 (C-11). Anal. Calcd. for C~23~H~18~N~6~O~4~S~2~: C, 54.54; H, 3.58; N, 16.60. Found: C, 54.47; H, 3.51; N, 16.55.

### *N*-\[2-(4-Hydroxyphenyl)-4-oxo-1,3-thiazolidin-3-yl\]-2-\[(6-methyl-1,3-benzothiazol-2-yl)amino\]pyridine-3-carboxamide (**6f**)

Brown solid, yield: 57 %, mp: 236--238 °C. IR (KBr) *ν* cm^−1^: 3320 (NH), 1717 (C=O of 4-thiazolidinone), 1646 (Aamide-I), 1556 (amide-II), 1228 (amide-III), 2872, 2942 (CH~3~), 3506 (OH). ^1^H NMR (400 MHz, DMSO-d*~6~*, TMS): δ 1.24 (s, 3H, H-18), 3.61 (s, 2H, H-9), 5.30 (s, 1H, H-26), 6.19 (s, 1H, H-10), 6.86--8.52 (m, 10H, H-4,5,6,13,15,16,21,22,24,25), 8.90 (s, 1H, H-7), 9.36 (s, 1H, H-19). ^13^C NMR (100MHz, DMSO-d*~6~*, TMS): δ 23.2 (C-18), 35.5 (C-9), 57.3 (C-10), 111.3 (C-3), 114.7 (C-16), 115.6 (C-22,24), 118.6 (C-5), 121.0 (C-13), 125.9 (C-15), 129.8 (C-12), 130.3 (C-21,25), 131.6 (C-20), 134.3 (C-14), 136.9 (C-4), 147.8 (C-6), 149.7 (C-17), 156.8 (C-23), 163.1 (C-2), 163.7 (C-7), 169.4 (C-8), 171.4 (C-11). Anal. Calcd. for C~23~H~19~N~5~O~3~S~2~: C, 57.85; H, 4.01; N, 14.68. Found: C, 57.78; H, 3.94; N, 14.60.

### *N*-\[2-(4-Methoxyphenyl)-4-oxo-1,3-thiazolidin-3-yl\]-2-\[(6-methyl-1,3-benzothiazol-2-yl)amino\]pyridine-3-carboxamide (**6g**)

Brown solid, yield: 51 %, mp: 249--251 °C. IR (KBr) *ν* cm^−1^: 3321 (NH), 1719 (C=O of 4-thiazolidinone), 1648 (amide-I), 1552 (amide-II), 1227 (amide-III), 2873, 2947 (CH~3~), 1036, 1189 (OCH~3~). ^1^H NMR (400 MHz, DMSO-d*~6~*, TMS): δ 1.24 (s, 3H, H-18), 3.64 (s, 2H, H-9), 3.82 (s, 3H, H-26), 6.23 (s, 1H, H-10), 6.93--8.55 (m, 10H, H-4,5,6,13,15,16,21,22,24,25), 8.92 (s, 1H, H-7), 9.35 (s, 1H, H-19). ^13^C NMR (100MHz, DMSO-d*~6~*, TMS): δ 21.7 (C-18), 35.5 (C-9), 55.2 (C-26), 59.6 (C-10), 111.9 (C-3), 112.6 (C-22,24), 114.5 (C-16), 118.7 (C-5), 120.9 (C-13), 125.8 (C-15), 128.9 (C-21,25), 129.8 (C-12), 130.9 (C-20), 134.4 (C-14), 136.8 (C-4), 148.1 (C-6), 149.3 (C-17), 157.9 (C-23), 163.3 (C-2), 164.6 (C-7), 169.4 (C-8), 171.5 (C-11). Anal. Calcd. for C~24~H~21~N~5~O~3~S~2~: C, 58.64; H, 4.34; N, 14.26. Found: C, 58.58; H, 4.29; N, 14.18.

### *N*-\[2-(4-Hydroxy-3-methoxyphenyl)-4-oxo-1,3-thiazolidin-3-yl\]-2-\[(6-methyl-1,3-benzothiazol-2-yl)amino\]pyridine-3-carboxamide (**6h**)

White solid, yield: 53 %, mp: 225--226 °C. IR (KBr) *ν* cm^−1^: 3318 (NH), 1718 (C=O of 4-thiazolidinone), 1647 (amide-I), 1556 (amide-II), 1224 (amide-III), 2876, 2944 (CH~3~), 1034, 1191 (OCH~3~), 3510 (OH). ^1^H NMR (400 MHz, DMSO-d*~6~*, TMS): δ 1.22 (s, 3H, H-18), 3.63 (s, 2H, H-9), 3.87 (s, 1H, H-26), 5.32 (s, 1H, H-27), 6.21 (s, 1H, H-10), 6.90--8.58 (m, 9H, H-4,5,6,13,15,16,21,22,25), 8.94 (s, 1H, H-7), 9.32 (s, 1H, H-19). ^13^C NMR (100MHz, DMSO-d*~6~*, TMS): δ 23.8 (C-18), 35.4 (C-9), 55.9 (C-26), 57.6 (C-10), 111.1 (C-3), 114.1 (C-25), 114.7 (C-16), 115.6 (C-22), 118.9 (C-5), 121.1 (C-13), 122.1 (C-21), 125.9 (C-15), 130.1 (C-12), 131.8 (C-20), 134.1 (C-14), 137.1 (C-4), 146.9 (C-24), 147.2 (C-23), 147.9 (C-6), 149.7 (C-17), 163.7 (C-2), 164.7 (C-7), 168.9 (C-8), 171.2 (C-11). Anal. Calcd. for C~24~H~21~N~5~O~4~S~2~: C, 56.79; H, 4.17; N, 13.81. Found: C, 56.71; H, 4.11; N, 13.73.

### *N*-\[2-(4-Hydroxy-3-methoxy-5-nitrophenyl)-4-oxo-1,3-thiazolidin-3-yl\]-2-\[(6-methyl-1,3-benzothiazol-2-yl)amino\]pyridine-3-carboxamide (**6i**)

Yellow solid, yield: 59 %, mp: 256--257 °C. IR (KBr) *ν* cm^−1^: 3511 (OH), 3321 (NH), 1715 (C=O of 4-thiazolidinone), 1646 (Amide-I), 1561 (Amide-II), 1226 (Amide-III), 2877, 2947 (CH~3~), 1035, 1192 (OCH~3~). ^1^H NMR (400 MHz, DMSO-d*~6~*, TMS): δ 1.23 (s, 3H, H-18), 3.62 (s, 2H, H-9), 3.85 (s, 1H, H-26), 5.35 (s, 1H, H-27), 6.20 (s, 1H, H-10), 6.87--8.56 (m, 8H, H-4,5,6,13,15,16,21,25), 8.91 (s, 1H, H-7), 9.34 (s, 1H, H-19). ^13^C NMR (100MHz, DMSO-d*~6~*, TMS): δ 23.4 (C-18), 35.7 (C-9), 55.7 (C-26), 57.3 (C-10), 111.7 (C-3), 116.9 (C-16), 118.8 (C-5,21), 120.2 (C-25), 121.1 (C-13), 125.9 (C-15), 130.1 (C-12), 132.9 (C-20), 134.0 (C-14), 136.2 (C-23), 136.9 (C-4), 137.6 (C-22), 147.8 (C-6), 149.7 (C-17), 152.1 (C-24), 163.5 (C-7), 163.8 (C-2), 169.7 (C-8), 171.6 (C-11). Anal. Calcd. for C~24~H~20~N~6~O~6~S~2~: C, 52.17; H, 3.65; N, 15.22. Found: C, 52.10; H, 3.58; N, 15.15.

### *N*-\[2-(Furan-2-yl)-4-oxo-1,3-thiazolidin-3-yl\]-2-\[(6-methyl-1,3-benzothiazol-2-yl)amino\]pyridine-3-carboxamide (**6j**)

Black solid, yield: 59 %, mp: 223--225 °C. IR (KBr) *ν* cm^−1^: 3419 (NH), 1715 (C=O of 4-thiazolidinone), 1645 (amide-I), 1558 (amide-II), 1225 (amide-III), 2874, 2948 (CH~3~). ^1^H NMR (400 MHz, DMSO-d*~6~*, TMS): δ 1.22 (s, 3H, H-18), 3.60 (s, 2H, H-9), 6.20 (s, 1H, H-10), 6.78--8.51 (m, 9H, H-4,5,6,13,15,16,21,22,23), 8.91 (s, 1H, H-7), 9.34 (s, 1H, H-19). ^13^C NMR (100MHz, DMSO-d*~6~*, TMS): δ 23.8 (C-18), 35.0 (C-9), 57.1 (C-10), 105.4 (C-22),109.7 (C-21), 111.2 (C-3), 116.5 (C-16), 118.9 (C-5), 121.1 (C-13), 125.9 (C-15), 130.1 (C-12), 134.0 (C-14), 137.0 (C-4), 141.5 (C-23), 147.3 (C-6), 149.7 (C-17), 151.1 (C-20), 163.1 (C-2), 163.8 (C-7), 169.1 (C-8), 170.9 (C-11). Anal. Calcd. for C~21~H~17~N~5~O~3~S~2~: C, 55.87; H, 3.80; N, 15.52. Found: C, 55.80; H, 3.72; N, 15.45.

Experimental protocol for Antimicrobial activity
------------------------------------------------

All the compounds were tested for their antibacterial and antifungal activity (MIC) *in vitro* by broth dilution method against two Gram positive *S. aureus* MTCC 96, *S. pyogenes* MTCC 442 and two Gram negative *E. coli* MTCC 443, *P. aeruginosa* MTCC 741 bacteria and three fungal species *C. albicans* MTCC 227, *A. niger* MTCC 282 and *A. clavatus* MTCC 1323. Ampicillin for antibacterial activity while griseofulvin for antifungal activity were used as a standard drug

The experimental protocol followed for antimicrobial activity was according to the same method as previously reported in literature \[[@b18-scipharm-2010-78-753], [@b19-scipharm-2010-78-753]\].
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![Numbering of substituted *N*'-benzylidene/(2-furylmethylene)-2-\[(6-methyl-1,3-benzothiazol-2-yl)amino\]nicotinohydrazides **5a--j**](scipharm-2010-78-753f1){#f1-scipharm-2010-78-753}

![Numbering of 4-Thiazolidinones **6a--j**](scipharm-2010-78-753f2){#f2-scipharm-2010-78-753}

![Reagents and conditions: (a) Ullmann condensation, Cu-Bronze, anhydrous K~2~CO~3~, DMF, reflux 5 h; (b) (i) SOCl~2~ and (ii) NH~2~NH~2~·H~2~O in CHCl~3~; (c) substituted aromatic aldehydes, DMF, reflux 5--6 h; (d) HSCH~2~COOH, anhydrous ZnCl~2~, 1,4-dioxane 12--14 h.](scipharm-2010-78-753f3){#f3-scipharm-2010-78-753}

###### 

Antibacterial and antifungal activities of **5a--j** and **6a--j**

  **Comp.**          **Minimal bactericidal concentration μg/ml**   **Minimal fungicidal concentration μg/ml**                                   
  ------------------ ---------------------------------------------- -------------------------------------------- ------ ------ -------- -------- --------
  **1**              150                                            150                                          200    250    250      500      500
  **2**              250                                            125                                          500    1000   1000     1000     1000
  **3**              500                                            1000                                         500    1000   500      250      250
  **4**              500                                            500                                          150    200    250      1000     1000
  **5a**             100                                            500                                          150    200    100      500      500
  **5b**             500                                            500                                          500    100    1000     1000     \>1000
  **5c**             500                                            500                                          1000   1000   1000     \>1000   \>1000
  **5d**             250                                            62.5                                         500    500    250      1000     1000
  **5e**             62.5                                           150                                          100    200    1000     500      500
  **5f**             200                                            250                                          150    250    1000     1000     1000
  **5g**             250                                            500                                          500    1000   150      500      500
  **5h**             200                                            200                                          62.5   62.5   \>1000   \>1000   \>1000
  **5i**             500                                            500                                          500    500    \>1000   500      \>1000
  **5j**             25                                             50                                           50     62.5   100      500      500
  **6a**             250                                            250                                          500    500    1000     1000     1000
  **6b**             500                                            500                                          150    500    150      1000     1000
  **6c**             500                                            1000                                         1000   100    \>1000   \>1000   \>1000
  **6d**             50                                             100                                          100    150    \>1000   1000     500
  **6e**             250                                            250                                          500    500    500      \>1000   \>1000
  **6f**             250                                            250                                          500    500    250      500      \>1000
  **6g**             62.5                                           200                                          500    500    1000     \>1000   500
  **6h**             200                                            500                                          500    500    1000     1000     1000
  **6i**             500                                            100                                          1000   100    \>1000   500      \>1000
  **6j**             100                                            62.5                                         25     100    500      1000     1000
  **Ampicillin**     100                                            100                                          250    100    --       --       --
  **Griseofulvin**   --                                             --                                           --     --     500      100      100
